John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
PUT
Roku
ROKU
$23.5B
| $3.55M | 0.01% |
+83,200
| New | +$3.04M |
|
|
GHDX
1227
DELISTED
Genomic Health, Inc.
GHDX
| $3.54M | 0.01% |
70,314
+6,276
| +10% | +$249K |
|
|
ILG
1228
DELISTED
ILG, Inc Common Stock
ILG
| $3.53M | 0.01% |
+106,867
| New | +$3.57M |
|
1229
PUT
Dollar General
DG
$27.6B
| $3.52M | 0.01% |
35,700
+19,700
| +123% | +$1.89M |
|
1230
Regal Rexnord
RRX
$10.8B
| $3.51M | 0.01% |
42,956
-34,335
| -44% | -$2.66M |
|
1231
DMC Global
BOOM
$139M
| $3.51M | 0.01% |
78,155
+11,654
| +18% | +$450K |
|
1232
Community Bank
CBU
$3.32B
| $3.5M | 0.01% |
+59,182
| New | +$3.45M |
|
1233
PUT
Kohl's
KSS
$2.08B
| $3.49M | 0.01% |
47,900
-32,900
| -41% | -$2.19M |
|
1234
PUT
Costco
COST
$431B
| $3.49M | 0.01% |
16,700
-11,300
| -40% | -$2.23M |
|
1235
CALL
Transocean
RIG
$6.44B
| $3.49M | 0.01% |
259,500
-116,300
| -31% | -$1.43M |
|
|
TAST
1236
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $3.49M | 0.01% |
234,823
+143,520
| +157% | +$1.73M |
|
1237
RELX
RELX
$63.4B
| $3.48M | 0.01% |
159,959
-51,758
| -24% | -$1.13M |
|
|
ALXN
1238
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.48M | 0.01% |
28,000
+8,900
| +47% | +$1.04M |
|
1239
Sunrun
RUN
$2.15B
| $3.47M | 0.01% |
264,081
+155,346
| +143% | +$1.69M |
|
|
CIM
1240
Chimera Investment
CIM
$973M
| $3.47M | 0.01% |
+63,257
| New | +$3.41M |
|
1241
NeoGenomics
NEO
$2.11B
| $3.47M | 0.01% |
+264,621
| New | +$2.91M |
|
|
WLL
1242
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $3.47M | 0.01% |
877
+438
| +100% | +$1.51M |
|
1243
Enterprise Financial Services Corp
EFSC
$2.3B
| $3.47M | 0.01% |
+64,278
| New | +$3.36M |
|
1244
Toro Company
TTC
$9.47B
| $3.46M | 0.01% |
57,515
-172,993
| -75% | -$10.4M |
|
1245
PUT
Occidental Petroleum
OXY
$60.1B
| $3.46M | 0.01% |
41,400
+29,000
| +234% | +$2.32M |
|
1246
iShares China Large-Cap ETF
FXI
$4.24B
| $3.46M | 0.01% |
+80,600
| New | +$3.77M |
|
1247
AtriCure
ATRC
$2.51B
| $3.46M | 0.01% |
127,873
+439
| +0.3% | +$10.3K |
|
|
AMTD
1248
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
| $3.45M | 0.01% |
63,000
+48,000
| +320% | +$2.86M |
|
|
REGI
1249
DELISTED
Renewable Energy Group, Inc.
REGI
| $3.45M | 0.01% |
+193,184
| New | +$2.99M |
|
|
BCOV
1250
DELISTED
Brightcove, Inc.
BCOV
| $3.45M | 0.01% |
357,203
+193,443
| +118% | +$1.78M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.